Skip to main content
Quest Diagnostics

Innovative tests

BRCAvantage™

BRCAvantage™

Genetic testing for BRCA1 and BRCA2 is available from Quest Diagnostics.

Breast and ovarian cancers are common cancers that affect women. But only some of them are hereditary.  Hereditary cancer can happen when a parent passes on a mutation (change) in a BRCA1 or BRCA2 gene to a son or daughter. Changes in these 2 genes cause about 3% to 5% of all cancers in the breast and up to 15% of all cancers in the ovary. Changes in the 2 genes also increase the risk for breast and/or prostate cancer in men.

Learn More
Female doctor and patient in personal protective equipment at medical exam.

Cardio IQ®

Cardio IQ®

A comprehensive approach for helping you assess cardiovascular risk, guide treatment, and monitor response.

The Cardio IQ® Report provides an in-depth analysis of your patient's cardiac health, based on a number of different factors, from basic lipids to lipoprotein subfractionation.

Learn More

Exames inovadores

Innovative tests

Ver Em Portuguese

Innovative tests

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.